This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Cern Corporation, Paul Scherrer Institut. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015
Title: Gerd Juergen Beyer: Innovator in Radioisotope Production
Introduction
Gerd Juergen Beyer is a notable inventor based in Challex, France. He has made significant contributions to the field of radioisotope production, particularly through his innovative methods that enhance the efficiency and purity of these essential materials.
Latest Patents
Beyer holds a patent for a "Method for production of radioisotope preparations and their use in life science, research, medical application and industry." This invention relates to a universal method for the large-scale production of high-purity carrier-free or non-carrier-added radioisotopes. The method employs various 'unit operations' derived from physics and material science, which have not been previously utilized for isotope production. The combination and optimization of these unit operations allow for either batch-wise operation or fully automated continuous production schemes. The radioisotopes produced are particularly suitable for creating radioisotope-labelled bioconjugates, as well as nanoparticles and microparticles.
Career Highlights
Throughout his career, Beyer has worked with prestigious institutions such as the Paul Scherrer Institute and CERN. His work has significantly impacted the fields of life sciences and medical applications, showcasing his expertise in radioisotope technology.
Collaborations
Beyer has collaborated with notable colleagues, including Helge Leif Ravn and Ulli Koester. These partnerships have furthered his research and development efforts in the field of radioisotope production.
Conclusion
Gerd Juergen Beyer is a pioneering inventor whose work in radioisotope production has advanced the capabilities of this critical technology. His innovative methods and collaborations continue to influence the fields of research and medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile